Авторизація
|
Європейський ринок пристроїв темічної абляції (European Thermal Ablation Devices Market) In the medical devices industry, the term “ablation”—primarily referring to radiofrequency or RF ablation—has become a common description attached to devices that “kill or remodel selective tissue without vaporizing the major structures themselves.” Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies that are commonly utilized in several established, growing, technology-driven medical treatment areas such as benign prostatic hyperplasia (BPH), cancer/tumor ablation, endometrial ablation/menorrhagia, and the treatment of chronic venous insufficiency/varicose veins.
Publisher: Medtech Insight
Combined, the European thermal ablation devices market—including sales derived from generators and energy-based catheters, electrodes/probes, disposables, procedure kits, and accessories used in the treatment of BPH, cancer/tumors, menorrhagia, and chronic venous insufficiency/varicose veins in the countries of France, Germany, Italy, Spain, and the United Kingdom—totaled more than an estimated $250 million. Despite ongoing European economic instability and severe budget constraints, each market segment profiled in this report is expected to increase at conservative yet positive compound annual growth rates over the next five years—ranging from approximately 2.6%-3.3%—due to growing demand, cost-efficiency and efficacy, the gradual adoption of improved, next-generation technologies, and an aging European population susceptible to various diseases/conditions. This dynamic report from Medtech Insight includes analyses of leading products, markets, competitors, and emerging medical device technologies and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, as well as selected aesthetic areas, including skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications discussed include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids. TABLE OF CONTENTS EXECUTIVE SUMMARY i. Overview of Thermal Ablation ii. European Market for Thermal Ablation Devices iii. Methodology Exhibit ES-1: Thermal Effects on Tissue Exhibit ES-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit ES-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 1. SELECTED EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency1.2 Selected European National Healthcare Profiles 1.2.1 France 1.2.2.1 Healthcare Organization and Reform 1.2.3 ItalyExhibit 1-1: European Union, Medical Device Risk Classification System Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020 Exhibit 1-3: France, Selected National Healthcare Statistics Exhibit 1-4: Germany, Selected National Healthcare Statistics Exhibit 1-5: Italy, Selected National Healthcare Statistics Exhibit 1-6: Spain, Selected National Healthcare Statistics Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. THERMAL ABLATION DEVICES OVERVIEW 2.1 Applications for Thermal Ablation 2.1.1 Aesthetics—Skin Rejuvenation and TighteningExhibit 2-1: Thermal Effects on Tissue Exhibit 2-2: The Accent Radiofrequency Platform Exhibit 2-3: The Pixel CO2 Fractional Laser System and Technology Exhibit 2-4: The Thermage CPT System Exhibit 2-5: Sublative and Sublime Skin Rejuvenation Technologies Exhibit 2-6: The TruSculpt Body Sculpting System Exhibit 2-7: The Cellulaze Cellulite Laser Workstation Exhibit 2-8: The Smartlipo LaserBodySculpting Workstations Exhibit 2-9: The LipoControl GPS Laser Assisted Lipolysis System Exhibit 2-10: A Step-by-Step LipoSonix Procedure Exhibit 2-11: The VelaShape II System Exhibit 2-12: The UltraShape Contour I Body Sculpting System Exhibit 2-13: The CoolSculpting System and Step-by-Step Process Exhibit 2-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia Exhibit 2-15: The CoreTherm System Exhibit 2-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System and Competitive Treatments Exhibit 2-17: The CoolWave and Targis Systems Exhibit 2-18: The Cooled ThermCath Advance Catheter Exhibit 2-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results Exhibit 2-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results Exhibit 2-21: The Prostiva Radiofrequency Therapy System Exhibit 2-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System Exhibit 2-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV Exhibit 2-24: The GreenLight High Performance System Exhibit 2-25: The GreenLight Xcelerated Performance System Exhibit 2-26: The MoXy Liquid Cooled Fiber Exhibit 2-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes Exhibit 2-28: The StarBurst SDE and MRI Electrodes Exhibit 2-29: The NanoKnife Low Energy Direct Current System and Electrode Probes Exhibit 2-30: The RF 3000 Generator and LeVeen Needle Electrode Exhibit 2-31: The Cool-tip RF Ablation System Exhibit 2-32: The Cool-tip RF Ablation System E Series Exhibit 2-33: The HALOFLEX System Exhibit 2-34: The SERF Ablation System Exhibit 2-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process Exhibit 2-36: The Evident MWA System Exhibit 2-37: The Acculis MTA System and Three-Step Procedure Exhibit 2-38: The Ablatherm Robotic HIFU System Exhibit 2-39: The ExAblate System Exhibit 2-40: Breast Cancer Treatment Using the ExAblate System Exhibit 2-41: The Three-Step Endometrial Ablation Process Using the Genesys Hydro ThermAblator System Exhibit 2-42: The Her Option Cryoablation System Exhibit 2-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems Exhibit 2-44: The NovaSure System and Step-by-Step Endometrial Ablation Process Exhibit 2-45: Selected Features of the Next-Generation NovaSure System Exhibit 2-46: Nucleoplasty Using Coblation Technology Exhibit 2-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression Exhibit 2-48: Renessa Treatment for Stress Urinary Incontinence Exhibit 2-49: The VenaCure EVLT System Exhibit 2-50: The SVS System for the Treatment of Varicose Veins Exhibit 2-51: The Venefit Targeted Endovenous Therapy System Exhibit 2-52: Endovenous Ablation Using the Venefit System Exhibit 2-53: Uterine Fibroid Treatment Using the ExAblate System Exhibit 2-54: Sonalleve Therapy 3. EUROPEAN THERMAL ABLATION DEVICES MARKET 3.1 Procedure Volumes 3.2 Market Forecast 3.3 Competitive Analysis 3.3.1 Benign Prostatic Hyperplasia Ablation3.4 Other Thermal Ablation Markets 3.4.1 AestheticsExhibit 3-1: Europe, Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016 Exhibit 3-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016 Exhibit 3-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016 Exhibit 3-4: 2011, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-5: 2016, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment Exhibit 3-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier Exhibit 3-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier Exhibit 3-8: 2011, Tumor Ablation Products Market, Share by Supplier Exhibit 3-9: 2011, Endometrial Ablation Products Market, Share by Supplier Exhibit 3-10: 2011, Endovenous Ablation Products Market, Share by Supplier Exhibit 3-11: Leading Nonsurgical Aesthetic Device Companies,Global Revenues, 2010-2011 Exhibit 3-12: 2011, Global Nonsurgical Aesthetic Devices Market, Share by Supplier Exhibit 3-13: 2012, Selected Nonsurgical Body Sculpting/Fat Reduction Systems 4. COMPANY PROFILES 4.1 AngioDynamics, Inc. 4.2 Boston Scientific Corporation 4.3 Covidien PLC 4.4 Endo Health Solutions, Inc. 4.5 Hologic, Inc. 4.6 InSightec LTD/Elbit Imaging LTD 4.7 Johnson & Johnson 4.8 Microsulis Medical LTD 4.9 Solta Medical, Inc. 4.10 Syneron Medical LTD 4.11 Zeltiq Aesthetics, Inc. Перекладач: translate.google.com Європейський ринок пристроїв темічної абляції (European Thermal Ablation Devices Market) Європейський ринок електрохірургічних пристроїв (European Electrosurgical Devices Market) Американський ринок приладів термічної абляції (U.S. Thermal Ablation Devices Market) Американський ринок електрохірургічних пристроїв (U.S. Electrosurgical Devices Market) |
Новини
13.01.2021 Вчені розповіли, що між кашлем та високим артеріальним тиском є зв'язок
12.01.2021 Вчені виявили, що рівень заліза у крові може впливати на тривалість життя людини 11.01.2021 Які продукти найкраще зміцнюють імунітет 06.01.2021 Вчені з'ясували, як у хворих на COVID-19 починається смертельна пневмонія 05.01.2021 Цікавий факт: музика зменшує біль після операцій 04.01.2021 Піна з рофлуміластом допомогла знизити симптоми псоріазу 30.12.2020 Запах риби чи сірки: після Covid-19 можливі нюхові галюцинації 29.12.2020 Вчені розповіли, що часте позіхання може бути досить інформативним стосовно здоров'я людини 28.12.2020 Британські вчені виявили «універсальний метод» лікування раку 25.12.2020 Інноваційний метод лікування глухоти розробили ізраїльські вчені 24.12.2020 Небезпечний для життя пульс назвали дослідники 23.12.2020 Вчені довели генетичний зв'язок між кольором волосся і імунною системою організму 22.12.2020 У більшості перехворілих на COVID-19 через пів року є антитіла: дослідження 21.12.2020 Українцям радять не їхати до низки регіонів Великої Британії через мутацію коронавірусу 18.12.2020 Лікар розповів, чому втрата нюху при COVID-19 хороший знак 17.12.2020 Діти легше переносять Covid. Учені з'ясували чому 16.12.2020 Золотистий стафілокок може бути ліками 15.12.2020 Названа нова причина захворювань кишечника: справа зовсім не в їжі 14.12.2020 Постковідний синдром – життя до та після 11.12.2020 Атрофія мозку. Несподівані наслідки COVID-19 |